DDDPlus statistics

info info

Citations per year

info

Popular tool citations

chevron_left ADMET property prediction chevron_right
info

Tool usage distribution map

Tool usage distribution map
info info

Associated diseases

Associated diseases
Want to access the full stats & trends on this tool?

DDDPlus specifications

Information


Unique identifier OMICS_16040
Name DDDPlus
Software type Package/Module
Interface Graphical user interface
Restrictions to use License purchase required
Input data The limited physicochemical and manufacturing data, the dissolution method
Operating system Unix/Linux
Computer skills Medium
Stability Stable
Maintained Yes

Versioning


No version available

Maintainer


  • person_outline DDDPlus Team

Additional information


A registration is needed to access to tools.

DDDPlus citation

library_books

Justification of disintegration testing beyond current FDA criteria using in vitro and in silico models

2017
Drug Des Devel Ther
PMCID: 5395276
PMID: 28442890
DOI: 10.2147/DDDT.S131213

[…] apparatus ii at various paddle speeds was performed for immediate and extended release formulations of metronidazole. dissolution profile fitting via ddsolver and dissolution profile predictions via dddplus™ were performed. the results showed that fickian diffusion and drug particle properties (dpp) were responsible for the dissolution of the ir tablets, and that formulation factors (eg, coning) […]


Want to access the full list of citations?
DDDPlus institution(s)
Simulations Plus, Inc., Lancaster, CA, USA

DDDPlus reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review DDDPlus